- Empagliflozin Intermediate
- (R)-(-)-3-Hydroxy tetrahydrofuran
- (3S)-3-[4-[(5-bromo-2-chloro phenyl) methyl] phenoxy] tetrahydrofuran
- (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy}tetrahydro-furan
- (R)-tetrahydrofuran-3-yl 4-methyl benzene sulfonate
- 2,3,4,6-Tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone
- (3S)-3-[4-[(5-bromo-2-chloro-phenyl) methyl] phenoxy] tetrahydrofuran
(3S)-3-[4-[(5-bromo-2-chloro phenyl) methyl] phenoxy] tetrahydrofuran
![(3S)-3-[4-[(5-bromo-2-chloro phenyl) methyl] phenoxy] tetrahydrofuran](assets/images/products/cas-915095-89-5-thumb.png)
| API Name | Empagliflozin Intermediate |
| Intermediate Name | (3S)-3-[4-[(5-bromo-2-chloro phenyl) methyl] phenoxy] tetrahydrofuran |
| CAS No. | 915095-89-5 |
| Stage | Commercial |
Disclaimer
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
I - Products protected by patents are developed solely for the R&D purpose intended to support regulatory submissions.
II - It is within the buyer's responsibility and liability to check the patent situation of the products in the import market(s).
